Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer's Disease

被引:16
作者
Ma, Ling-Zhi [1 ]
Wang, Zi-Xuan [2 ]
Wang, Zuo-Teng [1 ]
Hou, Xiao-He [1 ]
Shen, Xue-Ning [3 ,4 ]
Ou, Ya-Nan [1 ]
Dong, Qiang [3 ,4 ]
Tan, Lan [1 ]
Yu, Jin-Tai [3 ,4 ]
机构
[1] Qingdao Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China
[2] Qingdao Univ, Dept Geriatr Med, Affiliated Hosp, Qingdao, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Inst Neurol, Shanghai, Peoples R China
基金
国家重点研发计划; 美国国家卫生研究院; 中国国家自然科学基金; 加拿大健康研究院;
关键词
Calcium; Alzheimer’ s disease; Aβ (42); FDG-PET; Brain volume; COMPOSITE SCORE; DEMENTIA; ASSOCIATION; DIAGNOSIS; PEOPLE;
D O I
10.1007/s12640-020-00312-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Relationship between serum calcium and Alzheimer's disease (AD) remains unclear. The aim of this study is to test whether serum calcium is associated with other AD-associated biomarkers and could predict clinical progression in nondemented elders. This was a longitudinal population-based study. The sample was derived from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, which included 1224 nondemented elders: 413 cognitively normal (CN) and 811 mild cognition impairment (MCI). Associations were investigated between serum calcium and longitudinal changes in A beta/tau pathologic features, brain structure, cognitive function, and disease progression. Serum calcium concentrations increased with disease severity. Serum calcium predicted longitudinal cognitive decline and conversion from nondemented status to AD dementia (adjusted HR = 1.41, 95% CI 1.13-1.76). Furthermore, serum calcium levels were negatively correlated with CSF-A beta(42) (beta = - 0.558, P = 0.008), FDG-PET (beta = - 0.292, P < 0.001), whole brain volume (beta = - 0.148, P = 0.001), and middle temporal volume (beta = - 0.216, P = 0.042). Similar results were obtained in CN and MCI groups. Higher serum calcium status (even if not hypercalcemia) may increase the risk of AD in elders. Serum calcium is a useful biomarker in predicting clinical progression in nondemented elders. More researches are needed in the future to explore the underlying mechanism.
引用
收藏
页码:609 / 617
页数:9
相关论文
共 34 条
[1]   3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects [J].
Apostolova, Liana G. ;
Hwang, Kristy S. ;
Andrawis, John P. ;
Green, Amity E. ;
Babakchanian, Sona ;
Morra, Jonathan H. ;
Cummings, Jeffrey L. ;
Toga, Arthur W. ;
Trojanowski, John Q. ;
Shaw, Leslie M. ;
Jack, Clifford R., Jr. ;
Petersen, Ronald C. ;
Aisen, Paul S. ;
Jagust, William J. ;
Koeppe, Robert A. ;
Mathis, Chester A. ;
Weiner, Michael W. ;
Thompson, Paul M. .
NEUROBIOLOGY OF AGING, 2010, 31 (08) :1284-1303
[2]   Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function [J].
Bennett, DA ;
Schneider, JA ;
Wilson, RS ;
Bienias, JL ;
Arnold, SE .
ARCHIVES OF NEUROLOGY, 2004, 61 (03) :378-384
[3]   Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation [J].
Betzer, Cristine ;
Lassen, Louise Berkhoudt ;
Olsen, Anders ;
Kofoed, Rikke Hahn ;
Reimer, Lasse ;
Gregersen, Emil ;
Zheng, Jin ;
Cali, Tito ;
Gai, Wei-Ping ;
Chen, Tong ;
Moeller, Arne ;
Brini, Marisa ;
Fu, Yuhong ;
Halliday, Glenda ;
Brudek, Tomasz ;
Aznar, Susana ;
Pakkenberg, Bente ;
Andersen, Jens Peter ;
Jensen, Poul Henning .
EMBO REPORTS, 2018, 19 (05)
[4]   Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis [J].
Bolland, Mark J. ;
Grey, Andrew ;
Avenell, Alison ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[5]   Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis [J].
Bolland, Mark J. ;
Avenell, Alison ;
Baron, John A. ;
Grey, Andrew ;
MacLennan, Graeme S. ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :289
[6]   Calcium [J].
Bushinsky, DA ;
Monk, RD .
LANCET, 1998, 352 (9124) :306-311
[7]   Upregulation of the Sarco-Endoplasmic Reticulum Calcium ATPase 1 Truncated Isoform Plays a Pathogenic Role in Alzheimer's Disease [J].
Bussiere, Renaud ;
Oules, Benedicte ;
Mary, Arnaud ;
Vaillant-Beuchot, Loan ;
Martin, Cecile ;
El Manaa, Wejdane ;
Vallee, Deborah ;
Duplan, Eric ;
Paterlini-Brechot, Patrizia ;
Da Costa, Cristine Alves ;
Checler, Frederic ;
Chami, Mounia .
CELLS, 2019, 8 (12)
[8]   Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI) [J].
Crane, Paul K. ;
Carle, Adam ;
Gibbons, Laura E. ;
Insel, Philip ;
Mackin, R. Scott ;
Gross, Alden ;
Jones, Richard N. ;
Mukherjee, Shubhabrata ;
Curtis, S. McKay ;
Harvey, Danielle ;
Weiner, Michael ;
Mungas, Dan .
BRAIN IMAGING AND BEHAVIOR, 2012, 6 (04) :502-516
[9]   Rates of Formal Diagnosis in People Screened Positive for Dementia in Primary Care: Results of the DelpHi-Trial [J].
Eichler, Tilly ;
Thyrian, Jochen Rene ;
Hertel, Johannes ;
Koehler, Leonore ;
Wucherer, Diana ;
Dreier, Adina ;
Michalowsky, Bernhard ;
Teipel, Stefan ;
Hoffmann, Wolfgang .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (02) :451-458
[10]   A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment [J].
Gibbons, Laura E. ;
Carle, Adam C. ;
Mackin, R. Scott ;
Harvey, Danielle ;
Mukherjee, Shubhabrata ;
Insel, Philip ;
Curtis, S. McKay ;
Mungas, Dan ;
Crane, Paul K. .
BRAIN IMAGING AND BEHAVIOR, 2012, 6 (04) :517-527